The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of randomised placebo-controlled trials
Year: 2015
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: Increased plasma levels of von Willebrand factor antigen (vWF:Ag) are associated with high risk of coronary artery disease. The effect of statin therapy on vWF:Ag levels remains uncertain. Therefore the aim of this meta-analysis was to evaluate the effect of statin therapy on vWF:Ag Levels. A systematic multiple-database search was carried out to identify randomized controlled trials (RCTs) that investigated the effect of statins on plasma vWF:Ag levels. Random-effect meta-analysis of 21 treatment arms revealed a significant decrease in plasma vWF:Ag levels following statin therapy (SMD: -0.54, 95 %CI: -0.87, -0.21, p=0.001). In subgroup analyses, the greatest effect was observed with simvastatin (SMD: -1.54, 95 %CI: -2.92, -0.17, p=0.028) and pravastatin (SMD: -0.61, 95 %CI: -1.18, -0.04, p=0.035), but not with fluvastatin (SMD: -0.34, 95 %CI: -0.69, 0.02, p=0.065), atorvastatin (SMD: -0.23, 95 %CI: -0.57, 0.11, p=0.179) and rosuvastatin (SMD: -0.20, 95 % CI: -0.71, 0.30, p=0.431). The lowering effect of statins on plasma vWF:Ag levels was greater in the subset of studies lasting ≥ 12 weeks (SMD: -0.70, 95 %CI: -1.19, -0.22, p=0.005) compared with that of studies lasting < 12 weeks (SMD: -0.34, 95 %CI: -0.67, 0.003, p=0.052). Finally, low-intensity statin therapy was not associated with a significant reduction in vWF:Ag levels (SMD: -0.28, 95 %CI: -0.82, 0.27, p=0.320), but a significant effect was observed in high-intensity statin trials (SMD: -0.66, 95 %CI: -1.07, -0.24, p=0.002). This meta-analysis of available RCTs demonstrates a significant reduction in plasma vWF:Ag levels following statin therapy.
Source: Thrombosis and Haemostasis
DOI: 10.1160/th15-08-0620
Authors: Amirhossein Sahebkar, Corina Serban, Sorin Ursoniu, Dimitri P. Mikhailidis, Anetta Undas, Gregory Y. H. Lip, Vera Bittner, Kausik K. Ray, Gerald F. Watts, G. Kees Hovingh, Jacek Rysz, John J. P. Kastelein, Maciej Banach, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
Institutions: Mashhad University of Medical Sciences, The University of Western Australia, Royal Perth Hospital, Victor Babeș University of Medicine and Pharmacy Timișoara, The Royal Free Hospital, University College London, Jagiellonian University, John Paul II Hospital, Birmingham City Hospital, University of Birmingham, University of Alabama at Birmingham, Imperial College London, Amsterdam UMC Location University of Amsterdam, Medical University of Lodz
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2270949935
